News & Perspective

Feb 19, 2018

Feb 19, 2018
Drawing vaccine from a vial

Senate bill would jump-start universal flu vaccine efforts

The proposed law would direct $200 million a year for 5 years to research.

Jan 10, 2018

Jan 10, 2018
Cattle herd

MERS antibody treatment clears phase 1 trial

The therapy, which uses cattle antibodies to treat the virus in humans, has shown to be safe and well-tolerated.

Jan 10, 2018

News Scan for Jan 10, 2018

Ebola antibody findings
USDA egg product rule
1918 pandemic flu severity

Dec 05, 2017

Dec 05, 2017
Vaccinating teen girl

Phase 1 trials promising for 2 Zika vaccines, including shelved one

Trials of both an inactivated and a DNA vaccine showed good safety and immune response data.

Nov 30, 2017

Nov 30, 2017

Flu Scan for Nov 30, 2017

Feds on flu vaccine challenges
Mutation alteration for FluMist

Nov 06, 2017

Nov 06, 2017

News Scan for Nov 06, 2017

Strep burden, resistance threat
Salmonella probe ends
Ebola susceptibility
MDR-TB in Minnesota

Nov 03, 2017

Nov 03, 2017

ASP Scan (Weekly) for Nov 03, 2017

Livestock-related MRSA
Antimicrobial stewardship recognition
IV antibiotics for UTIs
MRSA vaccine candidate
MCR-1 in pigs
MRSA and patient-sharing
Pneumonia overprescribing
New CARB-X funding
Hospital ASPs
Wales superbug deaths decline
Antibiotics in nursing homes

Oct 31, 2017

Oct 31, 2017

Stewardship / Resistance Scan for Oct 31, 2017

New CARB-X funding
Hospital ASPs
Wales superbug deaths decline

Oct 11, 2017

Oct 11, 2017
Ebola vaccine study

Liberia trial finds Ebola vaccines yield year-long immune response

A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.

Oct 05, 2017

Oct 05, 2017

Flu Scan for Oct 05, 2017

Research and pandemic readiness
Reusable respirators
Monoclonal antibody partnership

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»